Long COVID across SARS‐CoV‐2 variants: Clinical features, pathogenesis, and future directions
Open Access
- 4 December 2024
- journal article
- Published by Wiley in MedComm – Future Medicine
- Vol. 3 (4)
Abstract
Long coronavirus disease (COVID) is characterized by persistent symptoms following severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and has emerged as a significant health concern. As SARS‐CoV‐2 evolved from the wild‐type strain to the Alpha, Beta, Delta, and Omicron variants, there may be a variant‐specific influence on long COVID akin to the acute disease. This review aims to summarize our current knowledge of variant‐specific influences in long COVID incidence, symptom profile as well as mechanisms of pathogenesis. We highlight that long COVID incidence may be lower with the Omicron variants. The symptom profile of long COVID may also show some dependence on the different variants, with a reduction in cardiopulmonary symptoms with more recent SARS‐CoV‐2 variants. This heterogeneity of long COVID may also be related to the variant‐specific differences in affecting the immune system, viral persistence, and autoimmunity. However, emerging data also suggest that vaccinations may play a big role in shaping the presentation of long COVID. We also highlight ongoing work on long COVID incidence and symptom profiles in populations infected only by the Omicron variants. This will be beneficial toward more useful disease definitions and the development of effective diagnostic and therapeutic strategies.Keywords
Funding Information
- Macau University of Science and Technology (FRG‐21‐037‐FMD, FRG‐22‐023‐FMD)
This publication has 202 references indexed in Scilit:
- Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 InfectionJAMA Internal Medicine, 2024
- The breadth of the neutralizing antibody response to original SARS‐CoV‐2 infection is linked to the presence of Long COVID symptomsJournal of Medical Virology, 2023
- Prevalence and risk factors of long COVID 6–12 months after infection with the Omicron variant among nonhospitalized patients in Hong KongJournal of Medical Virology, 2023
- Evaluation of Waning of SARS-CoV-2 Vaccine–Induced ImmunityJAMA Network Open, 2023
- The outbreak of SARS‐CoV‐2 Omicron lineages, immune escape, and vaccine effectivityJournal of Medical Virology, 2022
- Emergence of Omicron third lineage BA.3 and its importanceJournal of Medical Virology, 2022
- Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19JAMA Network Open, 2021
- Persistent Symptoms in Patients After Acute COVID-19JAMA, 2020
- Duration of SARS‐CoV‐2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID‐19Journal of Medical Virology, 2020
- Cytomegalovirus, Epstein‐Barr virus, and human herpesvirus‐6 infections in patients with myalgic еncephalomyelitis/chronic fatigue syndromeJournal of Medical Virology, 2020